What is BioInformatics?
BioInformatics Inc. is a key provider of market intelligence tailored for major suppliers within the life science, analytical instrument, and clinical diagnostic sectors. The company excels in both quantitative and qualitative market research, delivering customized consulting services designed to illuminate customer needs and drive business expansion. By cultivating an extensive network of over 55,000 scientists and biomedical researchers, BioInformatics leverages this community to generate actionable insights. Their comprehensive product suite includes in-depth market research reports, regular newsletters, and specialized tools, all aimed at equipping clients with the competitive edge needed in the dynamic life sciences landscape.
How much funding has BioInformatics raised?
BioInformatics has raised a total of $21M across 1 funding round:
Series B
$21M
Series B (2018): $21M, investors not publicly disclosed
What's next for BioInformatics?
The recent major strategic investment, alongside the overall significant capital raised, positions BioInformatics for accelerated growth and market penetration. This enterprise-level funding suggests a focus on scaling operations, enhancing technological capabilities, and potentially expanding its research community engagement. The company's trajectory indicates a strong emphasis on solidifying its leadership in market intelligence for the life sciences, likely involving strategic partnerships and further development of its data analytics platforms to meet evolving industry demands.
See full BioInformatics company page
